Karyopharm Therapeutics Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Sep 2013 | 2,057.51x | $0.17 | $343.80 |
| Dec 2014 | 80,170.60x | $0.01 | $561.45 |
| Mar 2015 | 30,973.06x | $0.01 | $198.75 |
| Sep 2017 | 40,904.85x | $0.00 | $144.00 |
| Dec 2018 | 281.83x | $0.50 | $140.55 |
| Dec 2019 | 459.67x | $0.63 | $287.55 |
| Dec 2020 | 158.81x | $1.46 | $232.20 |
| Dec 2021 | 34.82x | $2.77 | $96.45 |
| Dec 2022 | 26.58x | $1.92 | $51.00 |
| Dec 2023 | 10.15x | $1.28 | $12.98 |
| Dec 2024 | 0.00x | $17,177.65 | $10.14 |
| Dec 2025 | 0.00x | $13,357.75 | $7.31 |